Search Results 451-460 of 17829 for monoclonal antibody

  1. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  2. Trastuzumab-anns (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-anns is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

  3. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells. Participation eligibility. Participant ...

  4. Dostarlimab-gxly (intravenous route) - Side effects & uses - Mayo Clinic

    Dostarlimab-gxly is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

  5. Oncology (Medical) - Clinical trials

    ... monoclonal antibody, and compare them with clinical outcomes. Human Saliva as a Non-Invasive Tool for Cancer Diagnostics Using Surface-Enhanced Raman ...

  6. Hematology - Clinical trials

    ... monoclonal antibody, and compare them with clinical outcomes. Alternate ... The purpose of this study is to evaluate the immune and hematopoietic compartments in ...

  7. Naxitamab-gqgk (intravenous route) - Mayo Clinic

    This medicine is a GD2-binding monoclonal antibody. This medicine is to be given only by or under the direct supervision of your doctor. This product is ...

  8. Rituximab-arrx (intravenous route) - Side effects & uses - Mayo Clinic

    Rituximab-arrx is a monoclonal antibody. Rituximab-arrx injection is also used together with other medicines (eg, fludarabine and cyclophosphamide) to treat ...

  9. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  10. Trastuzumab-pkrb (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-pkrb is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...